News
Filters
Showing 1 - 4 out of 4 results
Patient Story
A BJC HealthCare Employee Reflects on His Recovery
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.
Patient Story
Restoring Hope: How a Breakthrough Treatment Helped a Teenager Defeat Epilepsy
Article